期刊
CELLULAR IMMUNOLOGY
卷 361, 期 -, 页码 -出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.cellimm.2021.104287
关键词
Galectin-9; Immunomodulation; Disease severity; Biomarkers
资金
- Department of Biotechnology (DBT), Government of India [BT/PR23862/MED/29/1234/2017]
- University Grants Commission (UGC), Government of India
Galectin-9 is a widely expressed protein involved in cell signaling and host-pathogen interactions. Recent studies have found elevated levels of Galectin-9 in various diseases, including cancer and autoimmune disorders.
Galectin-9 (Gal-9) is a beta-galactoside binding lectin known for its immunomodulatory role in various microbial infections. Gal-9 is expressed in all organ systems and localized in the nucleus, cell surface, cytoplasm and the extracellular matrix. It mediates host-pathogen interactions and regulates cell signalling via binding to its receptors. Gal-9 is involved in many physiological functions such as cell growth, differentiation, adhesion, communication and death. However, recent studies have emphasized on the elevated levels of Gal-9 in autoimmune disorders, viral infections, parasitic invasion, cancer, acute liver failure, atopic dermatitis, chronic kidney disease, type-2 diabetes, coronary artery disease, atherosclerosis and benign infertility-related gynecological disorders. In this paper we have reviewed the potential of Gal-9 as a reliable, sensitive and non-invasive biomarker of disease severity. Tracking changes in Gal-9 levels and its implementation as a biomarker in clinical practice will be an important tool to monitor disease activity and facilitate personalized treatment decisions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据